Stem Cell Recipes of Bone Marrow and Fish: Just What the Stroke Doctors Ordered

Eleonora Napoli, Cesar V. Borlongan

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Stem cell therapy for stroke has advanced from the laboratory to the clinic, but remains as an experimental treatment. Two lines of transplant regimens have emerged, namely the “early bird” peripheral injections in subacute stroke patients and the “late night” direct intracerebral treatments in chronic stroke patients. Autologous bone marrow-derived stem cells, which only required minimal manipulations during graft cell preparation, gained fast-track entry into the clinic, while gene modified stem cells necessitated overcoming more stringent regulatory criteria before they were approved for clinical use. Safety of the stem cell therapy can be declared from these clinical trials, but efficacy warrants further investigations. Here, we offer insights into the translation of cell therapy from the laboratory to the clinic, in the hopes that highlighting the lessons we learned from this experience will guide the optimization of functional outcomes of future clinical trials of stem cell therapy for stroke.

Original languageEnglish (US)
Pages (from-to)192-197
Number of pages6
JournalStem Cell Reviews and Reports
Volume13
Issue number2
DOIs
StatePublished - Apr 1 2017

Fingerprint

Cell- and Tissue-Based Therapy
Fishes
Stem Cells
Bone Marrow
Stroke
Clinical Trials
Transplants
Safety
Injections
Therapeutics
Genes

Keywords

  • Clinical trials
  • Ischemic stroke
  • Stem cell therapy
  • Translational research

ASJC Scopus subject areas

  • Cell Biology
  • Cancer Research

Cite this

Stem Cell Recipes of Bone Marrow and Fish : Just What the Stroke Doctors Ordered. / Napoli, Eleonora; Borlongan, Cesar V.

In: Stem Cell Reviews and Reports, Vol. 13, No. 2, 01.04.2017, p. 192-197.

Research output: Contribution to journalReview article

@article{2ac7a768d0024388be3e99a653412930,
title = "Stem Cell Recipes of Bone Marrow and Fish: Just What the Stroke Doctors Ordered",
abstract = "Stem cell therapy for stroke has advanced from the laboratory to the clinic, but remains as an experimental treatment. Two lines of transplant regimens have emerged, namely the “early bird” peripheral injections in subacute stroke patients and the “late night” direct intracerebral treatments in chronic stroke patients. Autologous bone marrow-derived stem cells, which only required minimal manipulations during graft cell preparation, gained fast-track entry into the clinic, while gene modified stem cells necessitated overcoming more stringent regulatory criteria before they were approved for clinical use. Safety of the stem cell therapy can be declared from these clinical trials, but efficacy warrants further investigations. Here, we offer insights into the translation of cell therapy from the laboratory to the clinic, in the hopes that highlighting the lessons we learned from this experience will guide the optimization of functional outcomes of future clinical trials of stem cell therapy for stroke.",
keywords = "Clinical trials, Ischemic stroke, Stem cell therapy, Translational research",
author = "Eleonora Napoli and Borlongan, {Cesar V.}",
year = "2017",
month = "4",
day = "1",
doi = "10.1007/s12015-016-9716-y",
language = "English (US)",
volume = "13",
pages = "192--197",
journal = "Stem Cell Reviews",
issn = "1550-8943",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - Stem Cell Recipes of Bone Marrow and Fish

T2 - Just What the Stroke Doctors Ordered

AU - Napoli, Eleonora

AU - Borlongan, Cesar V.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Stem cell therapy for stroke has advanced from the laboratory to the clinic, but remains as an experimental treatment. Two lines of transplant regimens have emerged, namely the “early bird” peripheral injections in subacute stroke patients and the “late night” direct intracerebral treatments in chronic stroke patients. Autologous bone marrow-derived stem cells, which only required minimal manipulations during graft cell preparation, gained fast-track entry into the clinic, while gene modified stem cells necessitated overcoming more stringent regulatory criteria before they were approved for clinical use. Safety of the stem cell therapy can be declared from these clinical trials, but efficacy warrants further investigations. Here, we offer insights into the translation of cell therapy from the laboratory to the clinic, in the hopes that highlighting the lessons we learned from this experience will guide the optimization of functional outcomes of future clinical trials of stem cell therapy for stroke.

AB - Stem cell therapy for stroke has advanced from the laboratory to the clinic, but remains as an experimental treatment. Two lines of transplant regimens have emerged, namely the “early bird” peripheral injections in subacute stroke patients and the “late night” direct intracerebral treatments in chronic stroke patients. Autologous bone marrow-derived stem cells, which only required minimal manipulations during graft cell preparation, gained fast-track entry into the clinic, while gene modified stem cells necessitated overcoming more stringent regulatory criteria before they were approved for clinical use. Safety of the stem cell therapy can be declared from these clinical trials, but efficacy warrants further investigations. Here, we offer insights into the translation of cell therapy from the laboratory to the clinic, in the hopes that highlighting the lessons we learned from this experience will guide the optimization of functional outcomes of future clinical trials of stem cell therapy for stroke.

KW - Clinical trials

KW - Ischemic stroke

KW - Stem cell therapy

KW - Translational research

UR - http://www.scopus.com/inward/record.url?scp=85008514570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008514570&partnerID=8YFLogxK

U2 - 10.1007/s12015-016-9716-y

DO - 10.1007/s12015-016-9716-y

M3 - Review article

C2 - 28064388

AN - SCOPUS:85008514570

VL - 13

SP - 192

EP - 197

JO - Stem Cell Reviews

JF - Stem Cell Reviews

SN - 1550-8943

IS - 2

ER -